X-ray Structure-Based Chemoinformatic Analysis Identifies Promiscuous Ligands Binding to Proteins from Different Classes with Varying Shapes
Abstract
:1. Introduction
2. Results
2.1. Target Classification
2.2. X-ray Structure-Based Identification of Single- and Multi-Class Ligands
2.3. Distribution of Multiclass Ligands
2.4. Comparison of Ligand Binding Modes
2.5. Molecular Properties
2.6. Representative Binding Modes
3. Discussion
4. Materials and Methods
4.1. X-ray Structures of Ligand-Target Complexes
4.2. Characterization of Crystallographic Ligands and Activity Data
4.3. Analysis of Ligand–Target Interactions
4.4. Binding Mode Comparison
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
Abbreviations
GO | Gene Ontology |
LC | Ligand carbon atom |
MCL | Multiclass ligands |
MTL | Multitarget ligands |
PDB | Protein Data Bank |
PDBe | Protein Data Bank in Europe |
RMSD | Root mean square deviation |
SCL | Single-class ligands |
References
- Hu, Y.; Bajorath, J. Entering the ‘Big Data’ era in medicinal chemistry: Molecular promiscuity analysis revisited. Future Sci. OA 2017, 3, FSO179. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hopkins, A.L. Network pharmacology: The next paradigm in drug discovery. Nat. Chem. Biol. 2008, 4, 682–690. [Google Scholar] [CrossRef]
- Peters, J.U. Polypharmacology–foe or friend? J. Med. Chem. 2013, 56, 8955–8971. [Google Scholar] [CrossRef] [PubMed]
- Rosini, M. Polypharmacology: The rise of multitarget drugs over combination therapies. Future Med. Chem. 2014, 6, 485–487. [Google Scholar] [CrossRef] [PubMed]
- Bolognesi, M.L.; Cavalli, A. Multitarget drug discovery and polypharmacology. ChemMedChem 2016, 11, 1190–1192. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hopkins, A.L.; Mason, J.S.; Overington, J.P. Can we rationally design promiscuous drugs? Curr. Opin. Struct. Biol. 2006, 16, 127–136. [Google Scholar] [CrossRef] [PubMed]
- Proschak, E.; Stark, H.; Merk, D. Polypharmacology by design: A medicinal chemist’s perspective on multitargeting compounds. J. Med. Chem. 2019, 62, 420–444. [Google Scholar] [CrossRef] [PubMed]
- Shoichet, B.K. Screening in a spirit haunted world. Drug. Discov. Today 2006, 11, 607–615. [Google Scholar] [CrossRef] [Green Version]
- Baell, J.B.; Walters, M.A. Chemical con artists foil drug discovery. Nature 2014, 513, 481–483. [Google Scholar] [CrossRef]
- Stumpfe, D.; Tinivella, A.; Rastelli, G.; Bajorath, J. Promiscuity of inhibitors of human protein kinases at varying data confidence levels and test frequencies. RSC Adv. 2017, 7, 41265–41271. [Google Scholar] [CrossRef] [Green Version]
- Jalencas, X.; Mestres, J. On the origins of drug polypharmacology. Med. Chem. Comm. 2013, 4, 80–87. [Google Scholar] [CrossRef]
- Jasial, S.; Hu, Y.; Bajorath, J. Determining the degree of promiscuity of extensively assayed compounds. PLoS ONE 2016, 11, e0153873. [Google Scholar] [CrossRef] [PubMed]
- Blaschke, T.; Miljković, F.; Bajorath, J. Prediction of different classes of promiscuous and nonpromiscuous compounds using machine learning and nearest neighbor analysis. ACS Omega 2019, 4, 6883–6890. [Google Scholar] [CrossRef]
- Gilberg, E.; Bajorath, J. Recent progress in structure-based evaluation of compound promiscuity. ACS Omega 2019, 4, 2758–2765. [Google Scholar] [CrossRef] [Green Version]
- Moya-García, A.; Adeyelu, T.; Kruger, F.A.; Dawson, N.L.; Lees, J.G.; Overington, J.P.; Orengo, C.; Ranea, J.A.G. Structural and functional view of polypharmacology. Sci. Rep. 2017, 7, e10102. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Haupt, J.V.; Daminelli, S.; Schroeder, M. Drug promiscuity in PDB: Protein binding site similarity is key. PLoS ONE 2013, 8, e65894. [Google Scholar] [CrossRef]
- Defranchi, E.; Schalon, C.; Messa, M.; Onofri, F.; Benfenati, F.; Rognan, D. Binding of protein kinase inhibitors to synapsin I inferred from pairwise binding site similarity measurements. PLoS ONE 2010, 5, e12214. [Google Scholar] [CrossRef]
- Gilberg, E.; Stumpfe, D.; Bajorath, J. X-ray structure based identification of compounds with activity against targets from different families and generation of templates for multi-target ligand design. ACS Omega 2018, 3, 106–111. [Google Scholar] [CrossRef]
- Gilberg, E.; Gütschow, M.; Bajorath, J. Promiscuous ligands from experimentally determined structures, binding conformations, and protein family dependent interaction hotspots. ACS Omega 2019, 4, 1729–1737. [Google Scholar] [CrossRef]
- The Gene Ontology Consortium. Gene Ontology: Tool for the unification of biology. Nat. Genet. 2000, 25, 25–29. [Google Scholar] [CrossRef] [Green Version]
- Westbrook, J.; Feng, Z.; Chen, L.; Yang, H.; Berman, H.M. The protein data bank and structural genomics. Nucleic Acids Res. 2003, 31, 489–491. [Google Scholar] [CrossRef]
- The Uniprot Consortium. Uniprot: The universal protein knowledgebase. Nucleic Acids Res. 2017, 45, D158–D169. [Google Scholar] [CrossRef] [PubMed]
- Cokelaer, T.; Pultz, D.; Harder, L.M.; Serra-Musach, J.; Saez-Rodriguez, J. Bioservices: A common python package to access biological web services programmatically. Bioinformatics 2013, 29, 3241–3242. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gutmanas, A.; Alhroub, Y.; Battle, G.M.; Berrisford, J.M.; Bochet, E.; Conroy, M.J.; Dana, J.M.; Fernandez Montecelo, M.A.; Van Ginkel, G.; Gore, S.P.; et al. PDBe: Protein data bank in Europe. Nucleic Acids Res. 2014, 42, D285–D291. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hastings, J.; Owen, G.; Dekker, A.; Ennis, M.; Kale, N.; Muthukrishnan, V.; Turner, S.; Swainston, N.; Mendes, P.; Steinbeck, C. ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res. 2016, 44, D1214–D1219. [Google Scholar] [CrossRef] [PubMed]
- Gaulton, A.; Hersey, A.; Nowotka, M.; Bento, A.P.; Chambers, J.; Mendez, D.; Mutowo, P.; Atkinson, F.; Bellis, L.J.; Cibrián-Uhalte, E.; et al. The ChEMBL database in 2017. Nucleic Acids Res. 2017, 45, D945–D954. [Google Scholar] [CrossRef]
- Wang, R.; Fang, X.; Lu, Y.; Yang, C.-Y.; Wang, S. The PDBbind database: Methodologies and updates. J. Med. Chem. 2005, 48, 4111–4119. [Google Scholar] [CrossRef]
- Weininger, D. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J. Chem. Inf. Comput. Sci. 1988, 28, 31–36. [Google Scholar] [CrossRef]
- OEChem TK; OpenEye Scientific Software: Santa Fe, NM, USA, 2012.
- RDKit: Open-Source Cheminformatics. Available online: http://www.rdkit.org (accessed on 2 March 2020).
- Dalby, A.; Nourse, J.G.; Hounshell, W.D.; Gushurst, A.K.I.; Grier, D.L.; Leland, B.A.; Laufer, J. Description of several chemical structure file formats used by computer programs developed at Molecular Design Limited. J. Chem. Inf. Comput. Sci. 1992, 32, 244–255. [Google Scholar] [CrossRef]
- Molecular Operating Environment (MOE), Version 2019.0101; Chemical Computing Group ULC: Montreal, QC, Canada. Available online: https://www.chemcomp.com/Products.htm (accessed on 5 March 2020).
- Shulman-Peleg, A.; Nussinov, R.; Wolfson, H.J. Recognition of functional sites in protein structures. J. Mol. Biol. 2004, 339, 607–633. [Google Scholar] [CrossRef]
Protein Class | Complexes | MCLs | Proteins |
---|---|---|---|
Enzyme regulator | 1 | 1 | 1 |
Hydrolase (C-N bonds, no peptides) | 32 | 9 | 31 |
Hydrolase (acid anhydrides) | 3 | 2 | 3 |
Hydrolase (ester bonds) | 17 | 13 | 11 |
Hydrolase (glycosyl bonds) | 9 | 7 | 8 |
Isomerase | 1 | 1 | 1 |
Ligase | 2 | 1 | 2 |
Lyase | 13 | 8 | 9 |
Oxidoreductase | 81 | 36 | 59 |
Peptidase | 11 | 8 | 10 |
Signaling receptor | 7 | 4 | 5 |
Transcription regulator | 19 | 14 | 10 |
Transferase (acyl groups) | 12 | 7 | 10 |
Transferase (alkyl or aryl groups, no methyl) | 28 | 6 | 21 |
Transferase (glycosyl groups) | 11 | 7 | 9 |
Transferase (one-carbon groups) | 22 | 8 | 16 |
Transferase (other) | 7 | 5 | 7 |
Transferase (phosphorus-containing groups) | 33 | 18 | 23 |
Transporter | 22 | 15 | 19 |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Feldmann, C.; Bajorath, J. X-ray Structure-Based Chemoinformatic Analysis Identifies Promiscuous Ligands Binding to Proteins from Different Classes with Varying Shapes. Int. J. Mol. Sci. 2020, 21, 3782. https://doi.org/10.3390/ijms21113782
Feldmann C, Bajorath J. X-ray Structure-Based Chemoinformatic Analysis Identifies Promiscuous Ligands Binding to Proteins from Different Classes with Varying Shapes. International Journal of Molecular Sciences. 2020; 21(11):3782. https://doi.org/10.3390/ijms21113782
Chicago/Turabian StyleFeldmann, Christian, and Jürgen Bajorath. 2020. "X-ray Structure-Based Chemoinformatic Analysis Identifies Promiscuous Ligands Binding to Proteins from Different Classes with Varying Shapes" International Journal of Molecular Sciences 21, no. 11: 3782. https://doi.org/10.3390/ijms21113782